ALFA Finder
11:14 IST
BSE
Other Announcement
Orchid Pharma Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Orchid Pharma Ltd
Orchid Pharma Ltd news stories on ALFA NewsRead the news →- Share price
- ₹866.70
- Market cap
- ₹5,190 Cr
- Revenue (annual)
- ₹811.3 Cr
- Net profit (annual)
- ₹20.55 Cr
- P/E (TTM)
- 598.8×Sector 43.8×
- Promoter holding
- 74.45%+4.61% QoQ
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 2Board Meeting Date 2Partnership 1Fund Raise 1Capital Structure Change 1Annual General Meeting 1Acquisition 1
Time
2 announcements with these filters
18:44 IST
BSE
Other Announcement
Orchid Pharma Other Announcement
Orchid Pharma Ltd has filed its quarterly Shareholding Pattern, providing a routine update on promoter and public shareholding as mandated by SEBI regulations.